• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗生素对大鼠布拉氏酵母菌恢复及动力学的影响。

Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in rats.

作者信息

Boddy A V, Elmer G W, McFarland L V, Levy R H

机构信息

Department of Pharmaceutics, University of Washington, Seattle 98195.

出版信息

Pharm Res. 1991 Jun;8(6):796-800. doi: 10.1023/a:1015822605815.

DOI:10.1023/a:1015822605815
PMID:2062812
Abstract

Saccharomyces boulardii (SB) is a yeast that is used for the prevention and treatment of antibiotic-associated diarrhea and for the treatment of pseudomembranous colitis. Since SB will most commonly be used when the bacterial flora of the gastrointestinal tract have been disrupted by antibiotic treatment, the influence of different antibiotics on the kinetics and recovery of SB in feces was investigated in rats. Following a single oral dose, SB concentrations in feces were measured for periods of 1 to 6 days. Although SB is eliminated exclusively in the feces, less than 3% of the dose is recovered as viable yeast. When rats were treated with neomycin, which is active against gram-negative aerobic bacteria but not against anaerobes, no change was observed in recovery of SB when compared with recovery from untreated rats. Also, there was no change in the rate at which SB concentrations declined in feces. In contrast, treatment with clindamycin and the broad-spectrum antibiotic ampicillin, which are active against anaerobes, produced an increase in the recovery of SB of up to seven times that of controls and slowed the rate of decline of SB concentration in the feces. This antibiotic effect on SB disposition was also found when SB was administered in multiple doses. An eightfold increase in the steady-state output of SB was observed from ampicillin-treated animals. Analysis of the recovery and kinetic data showed that the primary effect of these antibiotics was to reduce the destruction of SB, probably in the cecum and colon.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

布拉酵母菌(SB)是一种用于预防和治疗抗生素相关性腹泻以及治疗伪膜性结肠炎的酵母。由于SB最常用于胃肠道菌群已被抗生素治疗破坏的情况,因此在大鼠中研究了不同抗生素对粪便中SB动力学和恢复情况的影响。单次口服给药后,在1至6天内测量粪便中的SB浓度。虽然SB仅通过粪便排出,但作为活酵母回收的剂量不到3%。当用对革兰氏阴性需氧菌有活性但对厌氧菌无活性的新霉素治疗大鼠时,与未治疗大鼠相比,SB的回收率没有变化。而且,粪便中SB浓度下降的速率也没有变化。相反,用对厌氧菌有活性的克林霉素和广谱抗生素氨苄西林治疗,使SB的回收率提高到对照组的七倍,并减缓了粪便中SB浓度下降的速率。当多次给药SB时,也发现了这种抗生素对SB处置的影响。观察到氨苄西林治疗的动物中SB的稳态输出增加了八倍。对回收率和动力学数据的分析表明,这些抗生素的主要作用是减少SB的破坏,可能是在盲肠和结肠中。(摘要截短至250字)

相似文献

1
Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in rats.抗生素对大鼠布拉氏酵母菌恢复及动力学的影响。
Pharm Res. 1991 Jun;8(6):796-800. doi: 10.1023/a:1015822605815.
2
Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers.健康人类志愿者体内生物治疗剂布拉酵母菌的恢复与清除
Pharm Res. 1993 Nov;10(11):1615-9. doi: 10.1023/a:1018924820333.
3
Functional anatomy of the colonic bioreactor: Impact of antibiotics and Saccharomyces boulardii on bacterial composition in human fecal cylinders.结肠生物反应器的功能解剖学:抗生素和布拉氏酵母菌对人粪便柱中细菌组成的影响。
Syst Appl Microbiol. 2016 Feb;39(1):67-75. doi: 10.1016/j.syapm.2015.11.002. Epub 2015 Dec 14.
4
[Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment].[布拉氏酵母菌对抗生素治疗后树突状细胞特性及肠道微生物群紊乱的调节作用]
Gastroenterol Clin Biol. 2010 Sep;34 Suppl 1:S71-8. doi: 10.1016/S0399-8320(10)70024-5.
5
Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.布拉酵母菌CNCM I-745、阿莫西林-克拉维酸及其联合用药对健康志愿者肠道微生物群影响的前瞻性随机对照研究。
Gut Microbes. 2017 Jan 2;8(1):17-32. doi: 10.1080/19490976.2016.1267890. Epub 2016 Dec 14.
6
[A multicenter randomized controlled study of in the prevention of antibiotic-associated diarrhea in infants and young children].[关于预防婴幼儿抗生素相关性腹泻的多中心随机对照研究]
Zhonghua Er Ke Za Zhi. 2017 May 4;55(5):349-354. doi: 10.3760/cma.j.issn.0578-1310.2017.05.008.
7
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study.布拉氏酵母菌预防抗生素相关性腹泻的前瞻性研究。
Gastroenterology. 1989 Apr;96(4):981-8. doi: 10.1016/0016-5085(89)91613-2.
8
Molecular analysis of the digestive microbiota in a gnotobiotic mouse model during antibiotic treatment: Influence of Saccharomyces boulardii.抗生素治疗期间悉生小鼠模型中消化微生物群的分子分析:布拉酵母菌的影响
Anaerobe. 2008 Oct;14(4):229-33. doi: 10.1016/j.anaerobe.2008.04.003. Epub 2008 Apr 22.
9
Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study.预防性使用布拉酵母菌预防抗生素相关性腹泻:一项前瞻性研究。
Med Sci Monit. 2006 Apr;12(4):PI19-22. Epub 2006 Mar 28.
10
Effects of antibiotics and Saccharomyces boulardii on bacterial translocation in burn injury.抗生素和布拉氏酵母菌对烧伤后细菌移位的影响。
Surg Today. 2004;34(3):256-60. doi: 10.1007/s00595-003-2677-1.

引用本文的文献

1
Evaluation of the impact of polypeptide-p on diabetic rats upon its cloning, expression, and secretion in Saccharomyces boulardii.评价多肽-p 在酿酒酵母中克隆、表达和分泌对糖尿病大鼠的影响。
Arch Microbiol. 2023 Dec 23;206(1):37. doi: 10.1007/s00203-023-03773-9.
2
Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.通过基因工程益生菌酵母布拉氏酵母菌实现功能性异源蛋白表达。
PLoS One. 2014 Nov 12;9(11):e112660. doi: 10.1371/journal.pone.0112660. eCollection 2014.
3
S-Adenosyl-L-methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death.

本文引用的文献

1
FECAL DYE MARKERS IN METABOLIC BALANCE STUDIES. THE USE OF BRILLIANT BLUE AND METHYLCELLULOSE FOR ACCURATE SEPARATION OF STOOL PERIODS.代谢平衡研究中的粪便染料标记物。使用亮蓝和甲基纤维素准确区分排便时段。
Am J Clin Nutr. 1964 Feb;14:109-11. doi: 10.1093/ajcn/14.2.109.
2
Effect of clindamycin prophylaxis on the colonic microflora in patients undergoing colorectal surgery.克林霉素预防用药对结直肠手术患者结肠微生物群的影响。
Antimicrob Agents Chemother. 1981 Dec;20(6):736-40. doi: 10.1128/AAC.20.6.736.
3
[Comparative effect of a single or continuous administration of "Saccharomyces boulardii" on the establishment of various strains of "candida" in the digestive tract of gnotobiotic mice].
S-腺苷-L-蛋氨酸可保护益生菌酵母布拉氏酵母(Saccharomyces boulardii)免受酸性诱导的细胞死亡。
BMC Microbiol. 2013 Feb 13;13:35. doi: 10.1186/1471-2180-13-35.
4
Recombinant Saccharomyces cerevisiae strain expressing a model cytochrome P450 in the rat digestive environment: viability and bioconversion activity.在大鼠消化环境中表达模型细胞色素P450的重组酿酒酵母菌株:活力和生物转化活性。
Appl Environ Microbiol. 2007 Jun;73(11):3566-74. doi: 10.1128/AEM.02091-06. Epub 2007 Apr 6.
5
Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats.布拉酵母菌对蓖麻油诱导的大鼠腹泻的剂量反应关系及作用机制
Dig Dis Sci. 2003 Apr;48(4):770-4. doi: 10.1023/a:1022801228938.
6
Microecologic approaches for traveler's diarrhea, antibiotic-associated diarrhea, and acute pediatric diarrhea.针对旅行者腹泻、抗生素相关性腹泻和小儿急性腹泻的微生态疗法。
Curr Gastroenterol Rep. 1999 Aug;1(4):301-7. doi: 10.1007/s11894-999-0113-4.
7
Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats.布拉氏酵母菌可改善大鼠近端肠切除术后的细胞适应性。
Gut. 1999 Jul;45(1):89-96. doi: 10.1136/gut.45.1.89.
8
Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers.健康人类志愿者体内生物治疗剂布拉酵母菌的恢复与清除
Pharm Res. 1993 Nov;10(11):1615-9. doi: 10.1023/a:1018924820333.
[单剂量或连续给药“布拉酵母菌”对悉生小鼠消化道中各种念珠菌菌株定植的比较效果]
Ann Microbiol (Paris). 1982 Nov-Dec;133(3):491-501.
4
Bacterio-pharmacological activity of Saccharomyces boulardii in clindamycin-induced colitis in the hamster.
Arzneimittelforschung. 1984;34(7):794-7.
5
Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii.布拉氏酵母菌预防仓鼠克林霉素诱导的死亡
Antimicrob Agents Chemother. 1984 Oct;26(4):552-6. doi: 10.1128/AAC.26.4.552.
6
Colonization resistance of the digestive tract in conventional and antibiotic-treated mice.常规小鼠和抗生素处理小鼠消化道的定植抗性
J Hyg (Lond). 1971 Sep;69(3):405-11. doi: 10.1017/s0022172400021653.
7
On the mathematics of digesta flow kinetics.论消化物流动动力学的数学原理。
J Theor Biol. 1985 Apr 21;113(4):743-58. doi: 10.1016/s0022-5193(85)80191-0.
8
Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii.布拉氏酵母菌预防悉生小鼠艰难梭菌诱导的死亡
Can J Microbiol. 1986 Nov;32(11):894-6. doi: 10.1139/m86-164.
9
Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters.布拉氏酵母菌对万古霉素治疗后仓鼠中产毒艰难梭菌过度生长的抑制作用
Antimicrob Agents Chemother. 1987 Jan;31(1):129-31. doi: 10.1128/AAC.31.1.129.
10
Anaerobic infections and Clostridium difficile colitis emerging during antibacterial therapy.抗菌治疗期间出现的厌氧菌感染和艰难梭菌结肠炎。
Scand J Infect Dis Suppl. 1986;49:160-4.